Cientifica: How Nanotechnology is Revolutionizing Drug Delivery.LONDON -- Nanotechnology-enabled drug delivery systems (DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S ) are dramatically reshaping the way existing drugs are delivered, establishing new opportunities for drug formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating. American Law Institute Formulation and creating a host of new DDS companies resulting in the opening of a whole new era in the treatment of diseases. Cientifica, the world's leading independent supplier of nanotechnology nanotechnology: see micromechanics. nanotechnology Manipulation of atoms, molecules, and materials to form structures on the scale of nanometres (billionths of a metre). research and technology information, in its recently released free White Paper "The Nanotech Revolution in Drug Delivery" reveals that a new value paradigm has taken place in the drug delivery market in which pharma companies' existing compounds have new value. "At present, several hundred billion dollars worth of existing compounds which cannot be delivered properly are sitting in IP vaults unused," explains Hailing Yu, Research Director for Cientifica and principal author of the report. "The industry is keen to unlock and exploit this valuable intellectual property, and using nanotechnology to create New Chemical Entities (NCEs) via reformulation gives them the key." The impact on the DDS market is already significant, with Cientifica estimating that nano-enabled DDS already represents a $3.39 billion market and prompting a scramble To encode (encrypt) data in order to make it indecipherable without having a secret key to "unlock" it. The term came from the early days of cryptography which camouflaged analog transmissions with secret frequency patterns. by both large pharmaceutical companies and drug delivery start ups to grab a piece of a market predicted to grow to $26 billion by 2012, representing a compound annual growth rate of 37% over the next five years. "After that, the market is poised to explode (1) To break down an assembly into its component pieces. Contrast with implode. (2) To decompress data back to its original form. ," explains Cientifica CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Tim Harper, "with the fruits of today's research and development in both drug delivery systems and nanomaterials feeding through to create a market worth $220 billion by 2015." The revolutionary impact of nano-enabled also promises to transform the clinical treatment of patients with a range of diseases from cancer to dermatitis dermatitis (dûr'mətī`tĭs), nonspecific irritation of the skin. The causative agent may be a bacterium, fungus, or parasite; it can also be a foreign substance, known as an allergen. , and offers a range of delivery options for compounds that are either poorly soluble soluble /sol·u·ble/ (sol´u-b'l) susceptible of being dissolved. sol·u·ble adj. Capable of being dissolved, especially easily dissolved. or those that may also harm healthy tissue. The White Paper is a companion to Cientifica's recently released report "The Nanoparticle Drug Delivery Market", which identifies and analyses the companies and players that are likely to benefit as nanotechnology reshapes the drug delivery market. About Cientifica: Cientifica is the world's leading independent supplier of nanotechnology research and technology information, with activities spanning from basic research to consultancy, business intelligence and investments. See www.cientifica.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion